Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × Drug Therapy × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 13 Breast Neoplasms 12 Neoplasms 9 Carcinoma, Squamous Cell 8 Head and Neck Neoplasms 7 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Glioblastoma 6 Colorectal Neoplasms 6 Recurrence 5 Melanoma 5 Leukemia, Myeloid, Acute 5 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Lymphoma, Non-Hodgkin 4 Leukemia 4 Small Cell Lung Carcinoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Follicular 3 Fallopian Tube Neoplasms 3 Colonic Neoplasms 3 Brain Neoplasms 3 Treatment 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rectal Neoplasms 2 Mouth Neoplasms 2 Mesothelioma, Malignant 2 Lymphoma, T-Cell, Peripheral 2

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Whole-Body Irradiation 11 Peripheral Blood Stem Cell Transplantation 11 Etoposide 10 Tacrolimus 9 Mycophenolic Acid 7 Rituximab 6 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Alemtuzumab 3 thymoglobulin 2 prednylidene 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡